Thalassemia is inherited in an autosomal recessive pattern, meaning a child must receive a faulty gene from both parents to develop the disease. If both parents are carriers, each pregnancy carries a 25% chance of producing an affected child, a 50% chance of producing another carrier, and a 25% chance of producing a child who is completely unaffected. The genetics get more nuanced depending on whether you’re talking about alpha or beta thalassemia, because the two types involve different genes and different numbers of gene copies.
The Basics of Recessive Inheritance
Your body makes hemoglobin, the protein in red blood cells that carries oxygen, using two types of building blocks called alpha-globin and beta-globin chains. Thalassemia happens when genes responsible for making one of these chains are missing or mutated, leading to fewer functional red blood cells. Because thalassemia is recessive, carrying one faulty copy of a gene typically causes no symptoms or only very mild anemia. You need two faulty copies to develop significant disease.
This is why thalassemia can seem to appear “out of nowhere” in a family. Two perfectly healthy parents who are both silent carriers can have a child with severe anemia. Neither parent shows obvious signs, but each passes along one defective gene copy. Roughly 1.5% of the global population carries a beta-thalassemia gene variant, and the rates are much higher in specific regions: 12% to 15% in Cyprus, about 7% in Greece, and 1% to 11% across Arab countries. Alpha-thalassemia carrier rates reach 10% to 20% in parts of sub-Saharan Africa and are common throughout Southeast Asia.
How Beta Thalassemia Is Passed Down
Beta thalassemia involves mutations in a single gene called HBB, and you inherit one copy from each parent. A mutation can either completely shut down production of the beta-globin chain or reduce it. Complete shutdown is called beta-zero, while reduced production is called beta-plus. Which type you inherit from each parent helps determine how severe the disease becomes.
If you inherit two beta-zero mutations (one from each parent), you typically develop thalassemia major, the most severe form that requires regular blood transfusions starting in infancy. Inheriting two beta-plus mutations can result in a milder form called thalassemia intermedia, or sometimes thalassemia minor. A combination of one beta-zero and one beta-plus mutation can also cause thalassemia major. The clinical severity ultimately depends on how imbalanced your alpha and beta chain production becomes.
People with just one mutated copy are carriers, sometimes called having “beta-thalassemia trait.” They usually have mildly small red blood cells and may have slightly low hemoglobin, but they rarely need treatment. The important thing for carriers is knowing their status before having children, because if their partner is also a carrier, the math changes significantly for their offspring.
How Alpha Thalassemia Is Passed Down
Alpha thalassemia works differently because you have four copies of the alpha-globin gene rather than two: two on each copy of chromosome 16. The severity of alpha thalassemia depends on how many of those four genes are missing or nonfunctional, creating a spectrum with four distinct levels.
- One gene deleted (silent carrier): No symptoms. Blood tests look essentially normal, and most people never know they carry it.
- Two genes deleted (alpha-thalassemia trait): Mild anemia with slightly small red blood cells. Often mistaken for iron deficiency.
- Three genes deleted (Hemoglobin H disease): Moderate to severe anemia that may require occasional transfusions.
- Four genes deleted (Hemoglobin Bart hydrops fetalis): Almost always fatal before or shortly after birth. No functional alpha chains are produced at all.
Why the Arrangement of Deletions Matters
Here’s a subtlety in alpha thalassemia that catches many people off guard. Two deleted genes can be arranged in two different ways, and the arrangement dramatically affects the risk to your children. If both deletions sit on the same chromosome (called the cis arrangement), you carry one chromosome with zero working alpha genes and one chromosome with two normal genes. If the deletions are split across both chromosomes (the trans arrangement), each chromosome has one working gene and one deleted gene.
Both arrangements give you the same mild symptoms. But the cis arrangement is far more dangerous for reproduction. A parent with the cis pattern can pass along a chromosome with zero alpha genes. If their partner also carries a cis deletion, the couple can have a child who inherits zero working alpha genes from both sides, resulting in the fatal hydrops fetalis form. Two parents with the trans arrangement cannot produce this outcome, because each chromosome they pass along always carries at least one working gene.
The cis arrangement is more common in people of Southeast Asian and Mediterranean descent. The trans arrangement is more common in people of African descent. This is one reason hydrops fetalis is seen more frequently in Southeast Asian populations, even though alpha-thalassemia trait itself is common in Africa too.
What Carrier Testing Looks Like
Carrier status for beta thalassemia is usually identified through a standard blood test. Carriers tend to have smaller-than-average red blood cells and a slightly elevated level of a hemoglobin variant called HbA2, which normally makes up 2% to 3% of total hemoglobin. Alpha thalassemia carriers are harder to detect with routine blood work because their HbA2 levels tend to be low-normal (1.5% to 2.5%) rather than elevated. Genetic testing, which looks directly at the DNA, is often needed to confirm alpha thalassemia and determine the specific arrangement of deletions.
Once a carrier or affected person is identified in a family, testing extended relatives becomes especially valuable. This is sometimes called cascade screening. Parents, siblings, aunts, uncles, and cousins are offered testing so that carriers can be identified before they make reproductive decisions. Identifying unmarried carriers gives them the option of choosing a partner who is not a carrier or planning for prenatal testing if both partners turn out to carry the trait.
Prenatal and Preconception Options
When both partners are confirmed carriers, prenatal testing can determine whether the fetus is affected. The earliest option is chorionic villus sampling, which can be performed at 8 to 10 weeks of pregnancy by analyzing fetal DNA for known thalassemia mutations. Amniocentesis is another option, available at 14 to 20 weeks. Both methods use DNA amplification to check for specific mutations matched against a panel of known variants.
Couples who know their carrier status before pregnancy also have the option of preimplantation genetic testing during IVF, which identifies affected embryos before implantation. For many families in high-prevalence regions, these tools have significantly reduced the number of children born with severe thalassemia. In Cyprus, for example, where carrier rates are among the highest in the world, national screening programs have made carrier identification a routine part of family planning.